Hyperbaric oxygen therapy can ameliorate the EMT... (2018 study) Skip to main content
Clinical Study Medicine 2018

Hyperbaric oxygen therapy can ameliorate the EMT phenomenon in keloid tissue.

Zhang M, Liu S, Guan E, Liu H, Dong X, Hao Y, et al., Medicine, 2018

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared keloid tissue and skin from three groups of 9 people each: keloid patients, keloid patients who received hyperbaric oxygen therapy (HBOT), and people with normal skin.

What They Found

In a small clinical study of 27 people in three groups of 9, keloid patients who received HBOT had lower levels of several tissue markers linked to epithelial-to-mesenchymal transition (EMT) than keloid patients who did not. Blood flow in the keloid was measured with a laser Doppler flowmeter before HBOT and surgery, and it was significantly reduced after HBOT. Compared with the keloid group, the HBOT group had lower levels of vimentin, fibronectin, VEGF and HIF-1α. Levels of E-cadherin and ZO-1 were significantly higher, and their mRNA levels also rose after HBOT. The authors wrote that HBOT may be an effective therapy against the EMT phenomenon in keloid patients.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was small, with 9 patients per group, and it reported tissue and blood-flow measurements rather than clinical outcomes such as scar change, so it cannot show that HBOT helps keloid patients in practice.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 30024539
Year Published 2018
Journal Medicine
MeSH Terms Adolescent; Adult; Blotting, Western; Cadherins; Epithelial-Mesenchymal Transition; Female; Fibronectins; Fluorescent Antibody Technique; Humans; Hyperbaric Oxygenation; Hypoxia-Inducible Factor 1, alpha Subunit; Keloid; Laser-Doppler Flowmetry; Male; Middle Aged

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology